These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30138985)

  • 21. [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis].
    Shi T; Zhuang R; Zhou H; Wang F; Shao Y; Cai Z
    Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):124-9. PubMed ID: 25880979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.
    Kajor M; Kukla M; Waluga M; Liszka Ł; Dyaczyński M; Kowalski G; Żądło D; Berdowska A; Chapuła M; Kostrząb-Zdebel A; Bułdak RJ; Sawczyn T; Hartleb M
    Pol J Pathol; 2017; 68(2):117-127. PubMed ID: 29025245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats.
    Yin Y; Liu H; Zheng Z; Lu R; Jiang Z
    Biomed Pharmacother; 2019 Mar; 111():1290-1296. PubMed ID: 30841442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of GPR81 agonist on insulin resistance in rats with nonalcoholic fatty liver disease].
    Zhang Y; Lu QH; Cao HF; Zhang SR; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jul; 37(4):354-358. PubMed ID: 34374253
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of telmisartan on resistin expression in a rat model of nonalcoholic steatohepatitis and insulin resistance].
    Zhang Q; Wang Y; Liu Y; Yang Q; Wang X; Wang Q; Zhang C; Wang B
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):281-5. PubMed ID: 26133820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemerin gene expression is regulated by food restriction and food restriction-refeeding in rat adipose tissue but not in liver.
    Stelmanska E; Sledzinski T; Turyn J; Presler M; Korczynska J; Swierczynski J
    Regul Pept; 2013 Feb; 181():22-9. PubMed ID: 23328001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver.
    Krautbauer S; Wanninger J; Eisinger K; Hader Y; Beck M; Kopp A; Schmid A; Weiss TS; Dorn C; Buechler C
    Exp Mol Pathol; 2013 Oct; 95(2):199-205. PubMed ID: 23906870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
    Chen LL; Deng XQ; Li NX
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.
    Bekaert M; Ouwens DM; Hörbelt T; Van de Velde F; Fahlbusch P; Herzfeld de Wiza D; Van Nieuwenhove Y; Calders P; Praet M; Hoorens A; Geerts A; Verhelst X; Kaufman JM; Lapauw B
    Obesity (Silver Spring); 2016 Dec; 24(12):2544-2552. PubMed ID: 27768254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
    Zhang Z; Wang J; Wang H
    Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis.
    Gao X; Mi S; Zhang F; Gong F; Lai Y; Gao F; Zhang X; Wang L; Tao H
    Cardiovasc Diabetol; 2011 Oct; 10():87. PubMed ID: 21981776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
    Hatziagelaki E; Herder C; Tsiavou A; Teichert T; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M
    PLoS One; 2015; 10(5):e0124935. PubMed ID: 25933030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial.
    Joy TR; McKenzie CA; Tirona RG; Summers K; Seney S; Chakrabarti S; Malhotra N; Beaton MD
    World J Gastroenterol; 2017 Jan; 23(1):141-150. PubMed ID: 28104990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of aerobic exercise and dieting on chemerin and its receptor CMKLR1 in the livers of type 2 diabetic rats].
    Lin XJ; Yang HF; Wang XH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):426-430. PubMed ID: 29926587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of Electroacupunctrue Stimulation at "Fenglong"(ST 40) on Expression of SREBP-1 c in Non-alcoholic Fatty Liver Disease Rats].
    Yu M; Li G; Tang CL; Gao RQ; Feng QT; Cao J
    Zhen Ci Yan Jiu; 2017 Aug; 42(4):308-14. PubMed ID: 29072011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-canonical Wnt signaling contributes to development of non-alcoholic steatohepatitis in a rat model of type 2 diabetes mellitus].
    Tian F; Zhang YJ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):537-42. PubMed ID: 24074715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.